Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06011096
Other study ID # Erzurum Atatürk Üniversitesi
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2, 2022
Est. completion date August 9, 2023

Study information

Verified date August 2023
Source Ataturk University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is aimed to determine the late cord clamping with early skin-to-skin contact in primiparous pregnant women who delivered vaginally, according to placental separation time, separation method, amount of postpartum bleeding and postpartum comfort.


Description:

The research is an experimental type randomized controlled trial. The data of the research gathered in the delivery room clinic of Erzurum City Hospital affiliated to the Ministry of Health in Erzurum city center between 02.11.2022 and 10.06.2023. The study was completed with 126 primiparous pregnants, 63 of whom were controls and 63 of whom were experimental, randomized in the clinic. "Personal Information Form" and "Postpartum Comfort Scale" prepared by the researcher were used to collect the data of the study. control group - Pregnant women who met the criteria for admission to the delivery room were selected, the institution's routine policies were implemented. - The mother was informed about the study and written consent was obtained. - Hospital routine practices continued until birth. - The stopwatch is started the moment the baby is born. - After birth, the umbilical cord was clamped immediately without skin-to-skin contact between the mother and the baby, and the baby was taken to routine care. - Signs of placental separation were monitored with a stopwatch, and it was noted at what minute the symptoms were seen. - Placental delivery time and separation type were noted in the relevant part of the form. - According to the routines taken from each hospitalized patient in institutional policies, the volunteer's entry hemoglobin and hematocrit values were noted on the form. - The Personal Information Form consisting of 22 questions and the Postpartum Comfort scale were administered to the mother at the end of the follow-up period in the delivery room (2 hours later). - From the 6th hour blood values found in the hospital routine, the mother's hemoglobin and hematocrit values were noted on the form. Experimental group - Pregnant women who met the criteria for admission to the delivery room were selected, the institution's routine policies were implemented. - The mother was informed about the study and written consent was obtained. - Hospital routine practices continued until birth. - The stopwatch is started the moment the baby is born. - The baby was placed on the mother's chest, it was waited for 60-90 seconds in skin-to-skin contact, and breastfeeding was tried. At the end of the period, the umbilical cord was clamped and the baby was placed under a radiant heater and routine care was continued. - Signs of placental separation were monitored with a stopwatch, and it was noted at what minute the symptoms were seen. - Placental delivery time and separation type were noted in the relevant part of the form. - According to the routines taken from each hospitalized patient in institutional policies, the volunteer's entry hemoglobin and hematocrit values were noted on the form. - During the repair of episiotomy or desuria, if any, in the mother, skin-to-skin contact was made between the baby and the mother for 1 hour without disrupting the procedures. - The Personal Information Form consisting of 22 questions and the Postpartum Comfort scale were administered to the mother at the end of the follow-up period in the delivery room (2 hours later). - From the 6th hour blood values found in the hospital routine, the mother's hemoglobin and hematocrit values were noted on the form.


Recruitment information / eligibility

Status Completed
Enrollment 126
Est. completion date August 9, 2023
Est. primary completion date June 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria: - for pregnant women 1. Those who agreed to participate in the research 2. 18-49 years old 3. Firstborn (nulliparous) 4. Have 37-42 weeks of pregnancy 5. The baby in head presentation 6. No prenatal risk pregnancy 7. No risk during and after birth - for newborns 1. Absence of any health problems or congenital diseases, 2. No need for resuscitation after birth. 3. APGAR score of 8 points or more Exclusion Criteria: 1. Births less than 37 weeks 2. Multiparity 3. Any complications in the mother or baby 4. Removal of the placenta by intervention rather than spontaneous separation

Study Design


Intervention

Other:
skin-to-skin contact and delayed cord clamping
Placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated with skin-to-skin contact and late cord clamping after delivery.
avoiding skin-to-skin contact and early cord clamping
After delivery, placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated without skin-to-skin contact and late cord clamping.

Locations

Country Name City State
Turkey Erzurum City Hospital Erzurum

Sponsors (1)

Lead Sponsor Collaborator
Bahar GÖBEL

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Skin-to-skin contact and delayed cord clamping affect placental separation time. It shortens the placental separation time in women who have had a vaginal delivery with skin-to-skin contact and delayed clamping of the cord. 0-30 minute
Primary Skin-to-skin contact and delayed cord clamping affect the amount of postpartum bleeding. Skin-to-skin contact and delayed cord clamping reduce the amount of postpartum hemorrhage in women who deliver vaginally. 0-6 hours
Primary Skin-to-skin contact and delayed cord clamping have no effect on the type of placental separation. Determination of the effect of skin-to-skin contact and delayed cord clamping on the type of placental separation. 0-30 minute
Primary Skin-to-skin contact and delayed cord clamping affect the level of postpartum comfort. Increasing the postpartum comfort level of women who had vaginal delivery with skin-to-skin contact and delayed cord clamping. 2 hours
See also
  Status Clinical Trial Phase
Completed NCT03434444 - In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol N/A
Terminated NCT01980173 - Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care N/A
Not yet recruiting NCT06033170 - Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage N/A
Not yet recruiting NCT02319707 - Management of the Third Stage of Labor Phase 3
Completed NCT02163616 - Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study Phase 3
Recruiting NCT01600612 - Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial N/A
Completed NCT02079558 - Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section Phase 2
Withdrawn NCT01108302 - Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India N/A
Completed NCT00097123 - RCT of Misoprostol for Postpartum Hemorrhage in India N/A
Completed NCT02883673 - Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage N/A
Completed NCT02542813 - Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers Phase 1
Completed NCT04201665 - EMG for Uterotonic Efficiency Estimation N/A
Terminated NCT03246919 - Ideal Time of Oxytocin Infusion During Cesarean Section Phase 4
Not yet recruiting NCT05501106 - Reducing Postpartum Hemorrhage After Vaginal Delivery N/A
Completed NCT05429580 - Prophylactic Tranexamic Acid Use After Vaginal Delivery N/A
Terminated NCT03064152 - Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery N/A
Recruiting NCT05382403 - Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage N/A
Completed NCT02805426 - Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage Phase 4
Completed NCT03344302 - Oxytocin Administration During Cesarean Section Phase 4
Completed NCT02910310 - Introduction of UBT for PPH Management in Three Countries N/A